181 related articles for article (PubMed ID: 10861578)
1. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
van der Harst E; Bruining HA; Jaap Bonjer H; van der Ham F; Dinjens WN; Lamberts SW; de Herder WW; Koper JW; Stijnen T; Proye C; Lecomte-Houcke M; Bosman FT; de Krijger RR
J Pathol; 2000 Jun; 191(2):175-80. PubMed ID: 10861578
[TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.
de Krijger RR; van der Harst E; van der Ham F; Stijnen T; Dinjens WN; Koper JW; Bruining HA; Lamberts SW; Bosman FT
J Pathol; 1999 May; 188(1):51-5. PubMed ID: 10398140
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
5. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
6. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.
Unger P; Hoffman K; Pertsemlidis D; Thung S; Wolfe D; Kaneko M
Arch Pathol Lab Med; 1991 May; 115(5):484-7. PubMed ID: 1673596
[TBL] [Abstract][Full Text] [Related]
7. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
8. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
9. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression correlates with phaeochromocytoma malignancy: evidence for a Bcl-2-dependent mechanism.
Cadden IS; Atkinson AB; Johnston BT; Pogue K; Connolly R; McCance D; Ardill JE; Russell CF; McGinty A
Histopathology; 2007 Dec; 51(6):743-51. PubMed ID: 17916073
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
Nagura S; Katoh R; Kawaoi A; Kobayashi M; Obara T; Omata K
Mod Pathol; 1999 Dec; 12(12):1107-11. PubMed ID: 10619262
[TBL] [Abstract][Full Text] [Related]
12. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
13. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
Schröder S; Padberg B; Reincke M; Komminoth P
Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
Kolomecki K; Stepien H; Bartos M; Kuzdak K
Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
[TBL] [Abstract][Full Text] [Related]
16. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
[TBL] [Abstract][Full Text] [Related]
17. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH
Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound in the detection of adrenal tumours.
Päivänsalo M; Merikanto J; Kallioinen M; McAnsh G
Eur J Radiol; 1988 Aug; 8(3):183-7. PubMed ID: 3049088
[TBL] [Abstract][Full Text] [Related]
19. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]